Journal article icon

Journal article

Establishing a reliable framework for harnessing the creative power of the scientific crowd.

Abstract:

Discovering new medicines is difficult and increasingly expensive. The pharmaceutical industry has responded to this challenge by embracing open innovation to access external ideas. Historically, partnerships were usually bilateral, and the drug discovery process was shrouded in secrecy. This model is rapidly changing. With the advent of the Internet, drug discovery has become more decentralised, bottom-up, and scalable than ever before. The term open innovation is now accepted as just one of...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's version

Actions


Access Document


Files:
Publisher copy:
10.1371/journal.pbio.2001387

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, NDM, Structural Genomics Consortium
Role:
Author
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, NDM, Structural Genomics Consortium
Role:
Author
Publisher:
Public Library of Science Publisher's website
Journal:
PLoS Biology Journal website
Volume:
15
Issue:
2
Pages:
e2001387
Publication date:
2017-02-15
Acceptance date:
2017-01-01
DOI:
EISSN:
1545-7885
ISSN:
1544-9173
Pubs id:
pubs:681622
URN:
uri:99e3fe20-eacb-4faa-987e-f09d47f0b140
UUID:
uuid:99e3fe20-eacb-4faa-987e-f09d47f0b140
Local pid:
pubs:681622
Paper number:
2

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP